Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technosphere Insulin vs Placebo in T2DM
NCT00511602Phase 2Completed
- Sponsor
- MannKind
- Start
- Dec 2003
- Primary completion
- Nov 2004
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Technosphere Insulin with Placebo (2 arms). Primary endpoint: Hemoglobin A1c change from baseline at 12 weeks. Started Dec 2003; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00511602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511602.